Agency Forms Undergoing Paperwork Reduction Act Review, 58608-58609 [2017-26780]
Download as PDF
<![CDATA[
58608
Federal Register / Vol. 82, No. 238 / Wednesday, December 13, 2017 / Notices
Proposed Project
National Vital Statistics Report Forms
(OMB Control Number 0920–0213,
expires 04/30/2018)—Revision—
National Center for Health Statistics
(NCHS), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The compilation of national vital
statistics dates back to the beginning of
the 20th century and has been
conducted since 1960 by the Division of
Vital Statistics of the National Center for
Health Statistics, CDC. The collection of
the data is authorized by 42 U.S.C. 242k.
This submission requests approval to
collect the monthly and annually
summary statistics for three years.
immediately following the month of
occurrence.
The Annual Vital Statistics
Occurrence Report Form collects final
annual counts of marriages and divorces
by month for each State and Territory,
the District of Columbia, and New York
City as well as 33 counties in New
Mexico. These final counts are usually
available from State or county officials
about eight months after the end of the
data year. The data are widely used by
government, academic, private research,
and commercial organizations in
tracking changes in trends of family
formation and dissolution.
There are no costs to respondents
other than their time.
The Monthly Vital Statistics Report
forms provide counts of monthly
occurrences of births, deaths, and infant
deaths. Similar data have been
published since 1937 and are the sole
source of these data at the National
level. The data are used by the
Department of Health and Human
Services and by other government,
academic, and private research and
commercial organizations in tracking
changes in trends of vital events.
Respondents for the Monthly Vital
Statistics Reports Form are registration
officials in each State and Territory, the
District of Columbia, and New York
City. This form is also designed to
collect counts of monthly occurrences of
births, deaths, and infant deaths
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total burden
(in hours)
Type of respondents
Form name
State, Territory, and other officials ...
State, Territory, and New Mexico
County Officials.
Monthly Vital Statistics Report .........
Annual Vital Statistics Occurrence
Report.
58
91
12
1
8/60
30/60
93
46
Total ...........................................
...........................................................
........................
........................
........................
139
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2017–26782 Filed 12–12–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–17–1054]
sradovich on DSK3GMQ082PROD with NOTICES
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled Drug Overdose
Response Investigation (DORI) Data
Collections to the Office of Management
and Budget (OMB) for review and
approval. CDC previously published a
‘‘Proposed Data Collection Submitted
for Public Comment and
Recommendations’’ notice on July, 17,
2017 to obtain comments from the
public and affected agencies. CDC
received 10 comments related to the
previous notice. This notice serves to
VerDate Sep<11>2014
18:53 Dec 12, 2017
Jkt 244001
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
PO 00000
Frm 00021
Fmt 4703
Sfmt 4703
send an email to omb@cdc.gov. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, 725 17th Street NW,
Washington, DC 20503 or by fax to (202)
395–5806. Provide written comments
within 30 days of notice publication.
Proposed Project
Drug Overdose Response Investigation
(DORI) Data Collections (OMB Control
Number 0920–1054, Expiration 03/31/
2018)—Extension—National Center for
Injury Prevention and Control (NCIPC),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
In 2015, CDC received a three-year
OMB approval (OMB Control Number
0920–1054) for a new generic clearance
plan to collect information in response
to urgent requests from state and local
health authorities to provide
epidemiological information that allows
for the selection of interventions to curb
local epidemics of drug overdose. CDC
seeks OMB approval for an extension of
this generic clearance plan for another
three-year period.
Drug Overdose Response Investigation
(DORI) are to be conducted in response
to urgent requests from state and local
health authorities to provide
E:\FR\FM\13DEN1.SGM
13DEN1
58609
Federal Register / Vol. 82, No. 238 / Wednesday, December 13, 2017 / Notices
epidemiological information that allows
for the selection of interventions to curb
local epidemics of drug overdose. Of
particular interest is response to
increasing trends in, or changing
characteristics of, overdose from
prescription drugs (with a special
interest in opioid analgesics such as
oxycodone or methadone;
benzodiazepines such as alprazolam)
and/or illicit drugs (e.g., heroin). CDC’s
National Center for Injury Prevention
and Control (NCIPC) is frequently called
upon to conduct DORIs at the request of
state or local health authorities seeking
support to respond to urgent public
health problems resulting from drug
use, misuse, addiction, and overdose.
Such requests are typically, but not
always, made through the Epi-Aid
mechanism; in most investigations,
CDC’s epidemiological response entails
rapid and flexible collection of data that
evolves during the investigation period.
CDC requests this plan to ensure that
timely information is collected during a
DORI, which allows NCIPC to maintain
critical mission function by working
with state and local health authorities to
protect the public’s health. During an
unanticipated rise in nonfatal or fatal
drug overdose where the substances
responsible for the health event need to
be identified, drivers and risk factors are
undetermined, and/or subgroups at risk
need to be identified, immediate action
by CDC is necessary to minimize or
prevent public harm. CDC must have
the ability to rapidly deploy data
collection tools to understand the scope
of the problem and determine
appropriate action. Procedures for each
investigation, including specific data
collection plans, depend on the time
and resources available, number of
persons involved, and other
circumstances unique to the urgent
conditions at hand. Data are collected
by epidemiologists, psychologists,
medical professionals, subject matter
experts, and biostatisticians.
Data collected during a DORI are used
to understand sudden increases in drug
use and misuse associated with fatal
and nonfatal overdoses, understand the
drivers and risk factors associated with
those trends, and identify the groups
most affected. This allows CDC to
effectively advise states on actions that
could be taken to control the local
epidemic.
During a DORI, data are collected
once, with the rare need for follow-up.
The estimated annual burden hours are
1,000, there is no increase in the burden
hours from the previously approved
collection. There are no costs to
respondents other than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondents
Form name
Drug Overdose Response Investigation Participants.
DORI Data Collection Instruments .................
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2017–26780 Filed 12–12–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–18–0910; Docket No. CDC–2017–
0108]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
sradovich on DSK3GMQ082PROD with NOTICES
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
VerDate Sep<11>2014
18:53 Dec 12, 2017
Jkt 244001
You may submit comments,
identified by Docket No. CDC–2017–
0108 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Leroy A. Richardson,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road, NE, MS–
D74, Atlanta, Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
ADDRESSES:
AGENCY:
SUMMARY:
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on the
proposed extension of the existing
information Message Testing for
Tobacco Communication Activities
(MTTCA). CDC’s Office on Smoking and
Health has used the MTTCA clearance
to support the development and testing
of tobacco-related health messages,
including messages supporting CDC’s
National Tobacco Education Campaign
(NTEC) called the Tips from Former
Smokers® campaign.
DATES: CDC must receive written
comments on or before February 12,
2018.
PO 00000
Frm 00022
Fmt 4703
Sfmt 4703
2,000
Number of
responses per
respondent
Average
burden per
response
(in hours)
1
30/60
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Leroy A.
Richardson, Information Collection
Review Office, Centers for Disease
Control and Prevention, 1600 Clifton
Road, NE, MS–D74, Atlanta, Georgia
30329; phone: 404–639–7570; Email:
omb@cdc.gov.
FOR FURTHER INFORMATION CONTACT:
Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
SUPPLEMENTARY INFORMATION:
E:\FR\FM\13DEN1.SGM
13DEN1
]]>Agencies
[Federal Register Volume 82, Number 238 (Wednesday, December 13, 2017)]
[Notices]
[Pages 58608-58609]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-26780]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-17-1054]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled Drug Overdose Response Investigation (DORI)
Data Collections to the Office of Management and Budget (OMB) for
review and approval. CDC previously published a ``Proposed Data
Collection Submitted for Public Comment and Recommendations'' notice on
July, 17, 2017 to obtain comments from the public and affected
agencies. CDC received 10 comments related to the previous notice. This
notice serves to allow an additional 30 days for public and affected
agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to [email protected]. Direct written comments
and/or suggestions regarding the items contained in this notice to the
Attention: CDC Desk Officer, Office of Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by fax to (202) 395-5806. Provide
written comments within 30 days of notice publication.
Proposed Project
Drug Overdose Response Investigation (DORI) Data Collections (OMB
Control Number 0920-1054, Expiration 03/31/2018)--Extension--National
Center for Injury Prevention and Control (NCIPC), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
In 2015, CDC received a three-year OMB approval (OMB Control Number
0920-1054) for a new generic clearance plan to collect information in
response to urgent requests from state and local health authorities to
provide epidemiological information that allows for the selection of
interventions to curb local epidemics of drug overdose. CDC seeks OMB
approval for an extension of this generic clearance plan for another
three-year period.
Drug Overdose Response Investigation (DORI) are to be conducted in
response to urgent requests from state and local health authorities to
provide
[[Page 58609]]
epidemiological information that allows for the selection of
interventions to curb local epidemics of drug overdose. Of particular
interest is response to increasing trends in, or changing
characteristics of, overdose from prescription drugs (with a special
interest in opioid analgesics such as oxycodone or methadone;
benzodiazepines such as alprazolam) and/or illicit drugs (e.g.,
heroin). CDC's National Center for Injury Prevention and Control
(NCIPC) is frequently called upon to conduct DORIs at the request of
state or local health authorities seeking support to respond to urgent
public health problems resulting from drug use, misuse, addiction, and
overdose. Such requests are typically, but not always, made through the
Epi-Aid mechanism; in most investigations, CDC's epidemiological
response entails rapid and flexible collection of data that evolves
during the investigation period.
CDC requests this plan to ensure that timely information is
collected during a DORI, which allows NCIPC to maintain critical
mission function by working with state and local health authorities to
protect the public's health. During an unanticipated rise in nonfatal
or fatal drug overdose where the substances responsible for the health
event need to be identified, drivers and risk factors are undetermined,
and/or subgroups at risk need to be identified, immediate action by CDC
is necessary to minimize or prevent public harm. CDC must have the
ability to rapidly deploy data collection tools to understand the scope
of the problem and determine appropriate action. Procedures for each
investigation, including specific data collection plans, depend on the
time and resources available, number of persons involved, and other
circumstances unique to the urgent conditions at hand. Data are
collected by epidemiologists, psychologists, medical professionals,
subject matter experts, and biostatisticians.
Data collected during a DORI are used to understand sudden
increases in drug use and misuse associated with fatal and nonfatal
overdoses, understand the drivers and risk factors associated with
those trends, and identify the groups most affected. This allows CDC to
effectively advise states on actions that could be taken to control the
local epidemic.
During a DORI, data are collected once, with the rare need for
follow-up. The estimated annual burden hours are 1,000, there is no
increase in the burden hours from the previously approved collection.
There are no costs to respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Drug Overdose Response Investigation DORI Data Collection 2,000 1 30/60
Participants. Instruments.
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2017-26780 Filed 12-12-17; 8:45 am]
BILLING CODE 4163-18-P
